THE Australian Self Medication Industry (ASMI) announced its new Board of Directors at its annual general meeting last week, with the election of three board directors confirmed.
Rob Barnes (Aspen), Andrew Jenkin (Pfizer) and Alan Oppenheim (Ego Pharmaceuticals) will be joining current board directors Lindsay Forrest (chairman), Doug Cunningham (J&J Pacific ) and Mark Sargent (Bayer).
Following the AGM, the incoming board also appointed James Jones (Takeda) and Stephen Moodey (GSK) to fill two of the four casual vacancies.
The following office bearers were also appointed: Doug Cunningham to vice chair, James Jones to secretary and Rob Barnes as treasurer.
The AGM also featured guest speaker Craig Woolford, Citigroup md and head of consumer sector research, who addressed members on 'Amazon and its impact on the Australian market'.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 17
